Reporting of Factorial Randomized Trials
JAMA · 05.12.2023 · 330 (21) · 2106
DOI: 10.1001/jama.2023.19793 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift JAMA, erschienen am 05.12.2023. Verfasst von Brennan C Kahan und 14 weiteren Autor:innen. Beteiligte Einrichtung: MRC Clinical Trials Unit at UCL, London, United Kingdom. Hauptthemen laut MEDLINE: Disclosure, Randomized Controlled Trials as Topic, Research Design. Die Arbeit wurde bisher 90-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Medical Research Council.
Abstract (Originalsprache)
Importance Transparent reporting of randomized trials is essential to facilitate critical appraisal and interpretation of results. Factorial trials, in which 2 or more interventions are assessed in the same set of participants, have unique methodological considerations. However, reporting of factorial trials is suboptimal.
Objective
To develop a consensus-based extension to the Consolidated Standards of Reporting Trials (CONSORT) 2010 Statement for factorial trials.
Design
Using the Enhancing the Quality and Transparency of Health Research (EQUATOR) methodological framework, the CONSORT extension for factorial trials was developed by (1) generating a list of reporting recommendations for factorial trials using a scoping review of methodological articles identified using a MEDLINE search (from inception to May 2019) and supplemented with relevant articles from the personal collections of the authors; (2) a 3-round Delphi survey between January and June 2022 to identify additional items and assess the importance of each item, completed by 104 panelists from 14 countries; and (3) a hybrid consensus meeting attended by 15 panelists to finalize the selection and wording of items for the checklist.
Findings
This CONSORT extension for factorial trials modifies 16 of the 37 items in the CONSORT 2010 checklist and adds 1 new item. The rationale for the importance of each item is provided. Key recommendations are (1) the reason for using a factorial design should be reported, including whether an interaction is hypothesized, (2) the treatment groups that form the main comparisons should be clearly identified, and (3) for each main comparison, the estimated interaction effect and its precision should be reported. Conclusions and Relevance This extension of the CONSORT 2010 Statement provides guidance on the reporting of factorial randomized trials and should facilitate greater understanding of and transparency in their reporting.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- MRC Clinical Trials Unit at UCL, London, United Kingdom.
- Nottingham Clinical Trials Unit, School of Medicine, University of Nottingham, Nottingham, United Kingdom.
- Institute for Evidence-Based Healthcare, Bond University, Queensland, Australia.
- Women's College Research Institute, University of Toronto, Toronto, Ontario, Canada.
- London School of Hygiene and Tropical Medicine, London, United Kingdom.
- Primary Care Research Centre, School of Primary Care, Population Sciences and Medical Education, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
Förderung
- Medical Research Council
Zitieren
APA
Kahan, B. C., Hall, S. S., Beller, E. M., Birchenall, M., Chan, A. W., Elbourne, D., Little, P., Fletcher, J., Golub, R. M., Goulao, B., Hopewell, S., Islam, N., Zwarenstein, M., Juszczak, E., & Montgomery, A. A. (2023). Reporting of Factorial Randomized Trials. JAMA, 330(21), 2106. https://doi.org/10.1001/jama.2023.19793
Vancouver
Kahan BC, Hall SS, Beller EM, Birchenall M, Chan AW, Elbourne D, et al. Reporting of Factorial Randomized Trials. JAMA. 2023;330(21):2106. doi:10.1001/jama.2023.19793
BibTeX
@article{Kahan2023,
author = {Kahan, Brennan C and Hall, Sophie S and Beller, Elaine M and Birchenall, Megan and Chan, An-Wen and Elbourne, Diana and Little, Paul and Fletcher, John and Golub, Robert M and Goulao, Beatriz and Hopewell, Sally and Islam, Nazrul and Zwarenstein, Merrick and Juszczak, Edmund and Montgomery, Alan A},
title = {Reporting of Factorial Randomized Trials},
journal = {JAMA},
year = {2023},
volume = {330},
number = {21},
pages = {2106},
doi = {10.1001/jama.2023.19793}
}
EUVIMED